Literature DB >> 3691577

Stereoselective disposition of flupentixol: influence on steady-state plasma concentrations in schizophrenic patients.

A E Balant-Gorgia1, L P Balant, M Gex-Fabry, C Genet.   

Abstract

Steady-state plasma concentrations of cis(Z)-flupentixol (active principle) and trans(E)-flupentixol (inactive) were measured in 41 patients at least on one occasion. Results indicate that concentrations of the trans-isomer are significatively higher. This demonstrates that the two isomers are not handled in the same way by the organism. This may be relevant if plasma level monitoring is performed using non-specific analytical methods.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3691577     DOI: 10.1007/BF03189886

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  8 in total

1.  Pharmacodynamic and pharmacokinetic differences between drug enantiomers in humans: an overview.

Authors:  D E Drayer
Journal:  Clin Pharmacol Ther       Date:  1986-08       Impact factor: 6.875

Review 2.  The chromatographic analysis of enantiomers in drug metabolism studies.

Authors:  B Testa
Journal:  Xenobiotica       Date:  1986-03       Impact factor: 1.908

3.  A sensitive and specific radioimmunoassay for cis (Z)-flupenthixol in human serum.

Authors:  A Jørgensen
Journal:  Life Sci       Date:  1978-10-16       Impact factor: 5.037

4.  Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology.

Authors:  E J Ariëns
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

5.  Comparative determination of flupentixol in plasma by gas chromatography and radioimmunoassay in schizophrenic patients.

Authors:  A E Balant-Gorgia; L P Balant; C Genet; R Eisele
Journal:  Ther Drug Monit       Date:  1985       Impact factor: 3.681

6.  Plasma flupentixol concentrations and clinical response in acute schizophrenia.

Authors:  A E Balant-Gorgia; R Eisele; J M Aeschlimann; L P Balant; G Garrone
Journal:  Ther Drug Monit       Date:  1985       Impact factor: 3.681

7.  Pharmacokinetic studies in volunteers of intravenous and oral cis (Z)-flupentixol and intramuscular cis (Z)-flupentixol decanoate in Viscoleo.

Authors:  A Jørgensen
Journal:  Eur J Clin Pharmacol       Date:  1980-10       Impact factor: 2.953

8.  Serum concentrations of cis(Z)-flupentixol and prolactin in chronic schizophrenic patients treated with flupentixol and cis(Z)-flupentixol decanoate.

Authors:  A Jørgensen; J Andersen; N Bjørndal; S J Dencker; L Lundin; U Malm
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

  8 in total
  3 in total

1.  Flupentixol: relevance of stereoselective therapeutic drug monitoring.

Authors:  Pierre Baumann; Hartmut Kirchherr; Patricia Berney; Christoph Hiemke
Journal:  Psychopharmacology (Berl)       Date:  2012-04-04       Impact factor: 4.530

Review 2.  Antipsychotic drugs. Clinical pharmacokinetics of potential candidates for plasma concentration monitoring.

Authors:  A E Balant-Gorgia; L Balant
Journal:  Clin Pharmacokinet       Date:  1987-08       Impact factor: 6.447

Review 3.  Pharmacokinetic optimisation of the treatment of psychosis.

Authors:  A E Balant-Gorgia; L P Balant; A Andreoli
Journal:  Clin Pharmacokinet       Date:  1993-09       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.